We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.

Products, services, technology

We develop new bi-specific antibodies and cell therapies for oncology.


Route de la Corniche 4, 1066 Épalinges, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business